Disruption of TGF-β signaling in T cells accelerates atherosclerosis

Journal of Clinical Investigation

Volumn 112, Issue 9, 2003, Pages 1342-1350

  Robertson, Anna Karin L ^a   Rudling, Mats ^a   Zhou, Xinghua ^a   Gorelik, Leonid ^b   Flavell, Richard A ^c   Hansson, Göran K ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b BIOGEN   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; COLLAGEN; GAMMA INTERFERON; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL TISSUE; ANTIBODY RESPONSE; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; FEMALE; GENE DISRUPTION; HYPERCHOLESTEROLEMIA; IMMUNE RESPONSE; IMMUNITY; IMMUNOREGULATION; INFLAMMATION; KNOCKOUT MOUSE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

EID: 0346726036     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI18607     Document Type: Article

References (51)

1. Hansson, G.K., Holm, J., and Jonasson, L. 1989. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am. J. Pathol. 135:169-175.
2. van der Wal, A.C., Becker, A.E., van der Loos, C.M., and Das, P.K. 1994. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 89:36-44.
3. Hosono, M., et al. 2003. Increased expression of T cell activation markers (CD25, CD26, CD40L and CD69) in atherectomy specimens of patients with unstable angina and acute myocardial infarction. Atherosclerosis. 168:73-80.
4. Binder, C.J., et al. 2002. Innate and acquired immunity in atherogenesis. Nat. Med. 8:1218-1226.
5. Hansson, G.K. 2001. Immune mechanisms in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 21:1876-1890.
6. Hansson, G.K., Libby, P., Schonbeck, U., and Yan, Z.Q. 2002. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ. Res. 91:281-291.
7. Stemme, S., et al. 1995 T lymphocytes from human atherosclerotic: plaques recognize oxidized LDL. Proc. Natl. Acad. Sci. U. S. A. 92:3893-3897.
8. Mosorin, M., et al. 2000. Detection of chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of carotid artery. Arterioscler. Thromb. Vasc. Biol. 20:1061-1067.
9. Benagiano, M., et al. 2003. T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions. Proc. Natl. Acad. Sci. U. S. A. 100:6658-6663.
10. Zhou, X., Nicoletti, A., Elhage, R., and Hansson, G.K. 2000. Transfer of CD4 (+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation. 102:2919-2922.
11. Gupta, S., et al. 1997. IFN-γ potentiates atherosclerosis in apoE knock-out mice. J. Clin. Invest. 99:2752-2561.
12. Elhage, R., et al. 2003. Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. Cardiovasc. Res. 59:234-240.
13. Lutgens, E., et al. 1999. Requirement for CD154 in the progression of atherosclerosis. Nat. Med. 5:1313-1316.
14. Dansky, H.M., Charlton, S.A., Harper, M.M., and Smith, J.D. 1997. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc. Natl. Acad. Sci. U. S. A. 94:4642-4646.
15. Daugherty A., Puré, E., Delfel-Butteiger, D., Leferovich J., and Roselaar, S.E. 1997. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/-mice. J. Clin. Invest. 100:1575-1580.
16. Song, L., Leung, C., and Schindler, C. 2001. Lymphocytes are important in early atherosclerosis. J. Clin. Invest. 108:251-259. doi:10.1172/JCI200111380.
17. Gorelik, L., and Flavell, R.A. 2002. Transforming growth factor-beta in T-cell biology. Nat. Rev. Immunol. 2:46-53.
18. Grainger, D.J., Witchell, C.M., and Metcalfe, J.C. 1995. Tamoxifen elevates transforming growth factor-beta and suppresses diet-induced formation of lipid lesions in mouse aorta. Nat. Med. 1:1067-1073.
19. Pinderski, L.J., et al. 2002. Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes. Circ. Res. 90:1064-1071.
20. Caligiuri, G., et al. 2003. Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Mol. Med. 9:10-17.
21. Lutgens, E., et al. 2002. Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression. Arterioscler. Thromb. Vasc. Biol. 22:975-982.
22. Mallat, Z., et al. 2001. Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ. Res. 89:930-934.
23. Grainger, D.J., et al. 1995. The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis. Nat. Med. 1:74-79.
24. McCaffrey, T.A., et al. 1997. Genomic instability in the type II TGF-β1 receptor gene in atherosclerotic and restenotic vascular cells. J. Clin. Invest. 100:2182-2188.
25. McCaffrey, T.A. et al. 1999. The expression of TGF-beta receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor imbalance. J. Mol. Cell. Cardiol. 31:1627-1642.
26. Mallat, Z., and Tedgui, A. 2002. The role of transforming growth factor beta in atherosclerosis: novel insights and future perspectives. Curr. Opin. Lipidol. 13:523-529.
27. Gorelik, L., and Flavell, R.A. 2000. Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity. 12:171-181.
28. Nicoletti, A., Kaveri, S., Caligiuri, G., Bariety, J., and Hansson, G.K. 1998. Immunoglobulin treatment reduces atherosclerosis in apoE knockout mice. J. Clin. Invest. 102:910-918.
29. Gullberg, H., Rudling, M., Forrest, D., Angelin, B., and Vennstrom, B. 2000. Thyroid hormone receptor beta-deficient mice show complete loss of the normal cholesterol 7alpha-hydroxylase (CYP7A) response to thyroid hormone but display enhanced resistance to dietary cholesterol. Mol. Endocrinol. 14:1739-1749.
30. Zhou, X., Paulsson, G., Stemme, S., and Hansson, G.K. 1998. Hypercholesterolemia is associated with a Th1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. J. Clin. Invest. 101:1717-1725.
31. Libby, P., and Aikawa, M. 2002. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nat. Med. 8:1257-1262.
32. Iiyama, K., et al. 1999. Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ. Res. 85:199-207.
33. Trogan, E., et al. 2002. Laser capture microdissection analysis of gene expression in macrophages from atherosclerotic lesions of apolipoprotein E-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 99:2234-2239.
34. Palinski, W., Miller, E., and Witztum, J.L. 1995. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc. Natl. Acad. Sci. U. S. A. 92:821-825.
35. McCaffrey, T.A., et al. 1995. Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1. J. Clin. Invest. 96:2667-2675.
36. Grainger, D.J., Mosedale, D.E., Metcalfe, J.C., and Bottinger, E.P. 2000. Dietary fat and reduced levels of TGFbeta1 act synergistically to promote activation of the vascular endothelium and formation of lipid lesions. J. Cell Sci. 113:2355-2361.
37. Bottalico, L.A., Wager, R.E., Agellon, L.B., Assoian, R.K., and Tabas, I. 1991. Transforming growth factor-β1 inhibits scavenger receptor activity in THP-1 human macrophages. J. Biol. Chem. 266:22866-22871.
38. Han, J., et al. 2000. Transforming growth factor-beta1 (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma. J. Biol. Chem. 275:1241-1246.
39. Prud'homme, G.J., and Piccirillo, C.A. 2000. The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases. J. Autoimmun. 14:23-42.
40. Whitman, S.C., Ravisankar, P., and Daugherty, A. 2002. IFN-gamma deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E-/- mice. J. Interferon Cytokine Res. 22:661-670.
41. Mach, F., Schönbeck, U., Sukhova, G.K., Atkinson, E., and Libby, P. 1998. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature. 394:200-203.
42. Whitman, S.C., Ravisankar, P., and Daugherty, A. 2002. Interleukin-18 enhances atherosclerosis in apolipoprotein E (-/-) mice through release of interferon-gamma. Circ. Res. 90:E34-E38.
43. Mallat, Z., et al. 2001. Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ. Res. 89:E41-E45.
44. Laurat, E., et al. 2001. In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice. Circulation. 104:197-202.
45. King, V.L., Szilvassy, S.J., and Daugherty, A. 2002. Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-/- mice. Arterioscler. Thromb. Vasc. Biol. 22:456-461
46. Paulsson, G., Zhou, X., Tornquist, E., and Hansson, G.K. 2000. Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 20:10-17.
47. Xu, X.H., et al. 2001. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation. 104:3103-3108,
48. Edfeldt, K., Swedenborg, J., Hansson, G.K., and Yan, Z.Q. 2002. Expression of Toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation. 105:1158-1161.
49. Mach, F., et al. 1997. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages - implications for CD40-CD40 ligand signaling in atherosclerosis. Proc. Natl. Acad. Sci. U. S. A. 94:1931-1936.
50. Gerdes, N., et al. 2002. Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J. Exp. Med. 195:1-14.
51. Gojova, A., et al. 2003. Specific abrogation of transforming growth factor-β signaling in T cells alters atherosclerotic lesion size and composition in mice. Blood. doi:10.1182/blood-2003-05-1729.